Why does asthma become persistent?

American Journal of Respiratory and Critical Care Medicine

Volumn 153, Issue 6 II, 1996, Pages

  Barnes, Peter J ^a   Liew, F W ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CYCLOSPORIN A; CYTOKINE; GLUCOCORTICOID; IMMUNOGLOBULIN E; N(G) METHYLARGININE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PREDNISOLONE; STEROID; TRANSCRIPTION FACTOR;

ALLERGY; ASTHMA; BONE MARROW TRANSPLANTATION; CONFERENCE PAPER; ENVIRONMENTAL EXPOSURE; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; INHALATIONAL DRUG ADMINISTRATION; LUNG TRANSPLANTATION; NONHUMAN; OCCUPATIONAL ASTHMA; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SENSITIZATION;

ADOLESCENT; ADULT; ASTHMA; CHRONIC DISEASE; HUMANS; LUNG; RESPIRATORY HYPERSENSITIVITY;

EID: 0029977319     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm/153.6_pt_2.s23     Document Type: Article

References (18)

1. Chan-Yenug, M., and J. Malo. 1995. Occupational asthma. N. Engl. J. Med. 333:107-112.
2. Corris, P. A., and J.H. Dark. 1993. Aetiology of asthma: lessons from lung transplantation. Lancet 341:1369-1371.
3. Agosti, J. M., J. D. Sprengler, and L. G. Lum. 1988. Transfer of allergen specific IgE mediated hypersensitivity with allogenic bone marrow transplantation. N. Engl. J. Med. 319:1623-1628.
4. Selroos, O., R. Backman, K. Forsen, A. Löfroos, M. Nieistö, A. Pietinalcho, and A. Riska. 1994. When to start treatment of asthma with inhaled steroids? Eur. Respir. J. 7(Suppl. 18):151S.
5. Haahtela, T., M. Järvinsen, T. Kava, K. Kiviranta, S. Koskinen, K. Lemtonen, K. Nikander, T. Person, O. Selroos, A. Sovijäri, B. Stenius-Aarniala, T. Svahn, R. Tammivaara, and L. A. Laitinen. 1994. Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. N. Engl. J. Med. 331:700-705.
6. Ward, G. W., G. Karlsson, G. Rose, and T. A. E. Platts-Mills. 1989. Trichophyton asthma: sensitization of bronchi and upper airways to a dermatophyte antigen. Lancet 1:859-862.
7. Haczku, A., R. Moqbel, W. Elwood, J. Sun, A. B. Kay, P. J. Barnes, and K. F. Chung. 1994. Effects of prolonged repeated exposure to ovalbumin in sensitized Brown Norway rats. Am. J. Respir. Crit. Care Med. 150:23-27.
8. Holt, P. G. 1993. Regulation of antigen-presenting cell function(s) in lung and airway tissues. Eur. Respir. J. 6:120-129.
9. Aubus, P., B. Cosso, P. Godard, F. B. Miche, and J. Clot. 1984. Decreased suppressor cell activity of alveolar macrophages in bronchial asthma. Am. Rev. Respir. Dis. 130:875-878.
10. Spiteri, M. A., R. A. Knight, J. Y. Jeremy, P. J. Barnes, and K. F. Chung. 1994. Alveolar macrophage-induced suppression of peripheral blood mononuclear cell responsiveness is reversed by in vitro allergen exposure in bronchial asthma. Eur. Respir. J. 7:1431-1438.
11. 2. Lancet 344:436-438.
12. Lee, T. H. 1995. Lipoxin A,: a novel anti-inflammatory molecule? Thorax 50:111-112.
13. Nadel, J. A. 1991. Neutralendopeptidasemodulates neurogenicinflammation. Eur. Respir. J. 4:745-754.
14. Nijkamp, F. P., H. J. van der Linde, and G. Folkerts. 1993. Nitric oxide synthesis inhalations induce airway hyperresponsiveness in guinea pig in vivo and in vitro. Am. Rev. Respir. Dis. 148:727-734.
15. Vanhoutte, P. M. 1988. Epithelium derived relaxing factor: myth or reality? Thorax 43:665-668.
16. Bonfield, T. L., M. W. Konstan, P. Burfeind, J. R. Panuska, J. B. Hilliard, and M. Berger. 1995. Normal bronchial epithelial cells constitutively produce the antiinflammatory cytokine interleukin-10 which is down-regulated in cystic fibrosis. Am. J. Respir. Cell Mol. Biol. 13:257-261.
17. Nawata, Y., T. Koike, and T. Yanagisawa. 1984. Anti-IgE autoantibody in patients with bronchial asthma. Clin. Exp. Immunol. 58:348-356.
18. Shakib, F., J. Sihoe, S. J. Smith, P. Wilding, M. M. Clark, and A. Knox. 1994. Circulating levels of IgG1 and IgG4 anti-IgE antibodies and asthma severity. Allergy 49:192-195.